Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05735340 · ClinicalTrials.gov registry record · NA

Type 1 Diabetes Education and Support Study

A NA study of Type1diabetes, sponsored by Kaiser Permanente.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05735340 is a NA study of Type1diabetes that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 40 participants, below the 260-participant average among 19 other Type1diabetes trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05735340, a NA study of Type1diabetes, is active but no longer recruiting, sponsored by Kaiser Permanente.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Diabetes distress has been identified as one of the largest contributors to the racial disparity in glycemic control that disproportionately burdens Black patients ages 18-30 years with type 1 diabetes (T1D). In order to combat this issue, this study assesses the feasibility of the culturally tailored intervention T1DES and evaluates the effect of the T1DES intervention on diabetes outcomes in a pilot randomized clinical trial among Black young adults with T1D.

Conditions Studied

Interventions

  • BEHAVIORAL Diabetes Education
  • BEHAVIORAL T1DES

Study Locations (1)

Georgia

  • Kaiser Permanente Georgia - Atlanta

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-04-15
Est. Completion 2026-02-15
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT05735340

The ClinicalTrials.gov registry entry for NCT05735340 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 19 other Type1diabetes trials with a reported enrollment target (85% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type1diabetes appearing as the primary indexed condition, and to 2 interventions - of which Diabetes Education is the first listed.

NCT05735340 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05735340 about?

NCT05735340 is a clinical study titled "Type 1 Diabetes Education and Support Study". Diabetes distress has been identified as one of the largest contributors to the racial disparity in glycemic control that disproportionately burdens Black patients ages 18-30 years with type 1 diabetes (T1D). In order to combat this issue, this study assesses the feasibility of the culturally tailor...

What is the current status of trial NCT05735340?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-04-15. Estimated completion is 2026-02-15.

What conditions does trial NCT05735340 study?

This clinical trial studies the following conditions: Type1diabetes.

What interventions are being tested in trial NCT05735340?

The interventions under investigation include: Diabetes Education (BEHAVIORAL), T1DES (BEHAVIORAL).

Who is sponsoring clinical trial NCT05735340?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05735340 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type1diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.